TRIPLE POINT VCT 2011 PLC — Share Issue/Capital Change 2019

Mar 29, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5249U

Triple Point VCT 2011 PLC

29 March 2019

LEI: 213800AOOAQA5XQDEA89

Triple Point VCT 2011 plc

Issue of Equity and Total Voting Rights

First Allotment

The Directors of Triple Point VCT 2011 plc (the "Company") are pleased to announce the allotment of 4,292,687 Venture Shares of 1p each at an average price of 102.385p per share on 29 March 2019 pursuant to the offer for subscription set out in a prospectus issued by the Company on 14 September 2018. 

The shares allotted are to be admitted to the Official List. Admission is expected to become effective on or around 12 April 2019.

As a consequence of this allotment the issued share capital and total voting rights of the Company is now 21,068,086:

9,951,133 A Ordinary Shares

6,824,266 B Ordinary Shares

4,292,687 Venture Shares

Included in the issue of equity that took place was an allotment to Directors of the Company as follows:

Jane Owen                    24,499 Venture Shares at a price of 102.041p per share

Chad Murrin                 24,437 Venture Shares at a price of 102.302p per share

Timothy Clarke             24,499 Venture Shares at a price of 102.041p per share

Following the allotment, their shareholding in the Company is as follows:

	Number of Shares			% of Total Issued Share Capital
	A	B	Venture
Jane Owen	24,624	24,378	24,499	0.3%
Chad Murrin	24,874	24,624	24,437	0.4%
Tim Clarke	0	24,624	24,499	0.2%

For further information please contact Belinda Thomas or Jonathan Parr at Triple Point Investment Management LLP on 020 7201 8990.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCMMGZFFLZGLZM